Oral neoplasm

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
4 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Platinum compound 2 substances
Macrolide / aminoglycoside 1 substance
Antimetabolite 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic
    BLEOMYCIN SULFATE; CARBOPLATIN; CISPLATIN; FLUOROURACIL
    2025-520735-16-00 1 country n=96
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
IRCCS Istituto Nazionale Tumori Fondazione Pascale Academic 1 Phase II 0
← All indication landscapes